Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Exxel Pharma logo — Advancing Breakthrough Therapeutics to Transform the Treatme...

Exxel Pharma

Advancing Breakthrough Therapeutics to Transform the Treatment of Neuronal Hypersensitivity Disorders.

Founded 2017 United States Aurora, United States 4 employees Health Care, Pharmaceutical

General Information

Company Name Exxel Pharma
Founded Year 2017
Location United States Aurora, United States +1
Employees 4
Industries Health Care, Pharmaceutical
Social

Get notified when Exxel Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exxel Pharma

Exxel Pharma is a privately held company founded in 2017 with a focus on developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The company's lead program, EX937, is a first-in-class, proprietary small molecule designed for refractory chronic cough, an underserved market affecting approximately 10% of the global population. EX937 leverages a differentiated approach by inhibiting the FAAH enzyme, demonstrating efficacy and favorable safety in modulating chronic cough in preclinical models. The company is rapidly advancing the development of EX937 towards a first-in-human Phase 1/1b study. Additionally, EX937 holds the potential to be utilized across blockbuster indications including hyperactive bladder, peripheral neuropathic pain, and migraine headaches. Despite the absence of specific information regarding headquarter location and recent investment details, Exxel Pharma's dedication to addressing unmet medical needs and its unique therapeutic approach presents promising opportunities in the Health Care and Pharmaceutical industries for potential investors.

Taxonomy: Neuronal hypersensitivity disorders, Therapeutics development, Small molecule therapeutics, Chronic cough treatment, FAAH enzyme inhibition, Preclinical studies, Phase 1/1b study, Hyperactive bladder treatment, Neuropathic pain treatment, Migraine headache treatment, Drug development, Biopharmaceuticals, Neurology, Clinical trials, Medical research

No funding data available for Exxel Pharma yet.

Get notified when Exxel Pharma raises funding

Exxel Pharma Alternatives & Competitors

Exxel Pharma vs
Melius Pharma
Melius Pharma Sweden

Clinical stage biopharma company developing treatments for diseases with high unmet needs at a reduc...

Series A
3 employees
Health Care, Pharmaceutical
Exxel Pharma vs
NeRRe Therapeutics Ltd
NeRRe Therapeutics Ltd United Kingdom

Developing a breakthrough treatment for the disabling chronic cough associated with idiopathic pulmo...

Series B
9 employees
Biotechnology, Health Care
Exxel Pharma vs
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. United States

Clinical-stage biopharmaceutical company

Post Ipo Equity
34 employees
Biotechnology, Health Care

FAQ About Exxel Pharma

Advancing Breakthrough Therapeutics to Transform the Treatment of Neuronal Hypersensitivity Disorders.
Exxel Pharma was founded in 2017.
Exxel Pharma is headquartered in Aurora, United States.
Exxel Pharma operates in the following industries: Health Care, Pharmaceutical.
Exxel Pharma has approximately 4 employees.
Top alternatives and competitors to Exxel Pharma include Melius Pharma, NeRRe Therapeutics Ltd, Trevi Therapeutics, Inc., Hyfe, BIODOL THERAPEUTICS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exxel Pharma and Melius Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exxel Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy